🇺🇸 FDA
Pipeline program

elafibranor, Elafibranor Placebo

CLIN-60190-463

Phase 3 small_molecule active

Quick answer

elafibranor, Elafibranor Placebo for Primary Biliary Cholangitis (PBC) is a Phase 3 program (small_molecule) at Ipsen Pharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Ipsen Pharma
Indication
Primary Biliary Cholangitis (PBC)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials